Kura Oncology Inc
(FRA:KUR)
€
18.41
-0.035 (-0.19%)
Market Cap: 1.41 Bil
Enterprise Value: 938.19 Mil
PE Ratio: 0
PB Ratio: 3.02
GF Score: 36/100 - Q1 2024 Kura Oncology Inc Earnings Call TranscriptMay 02, 2024€18.75 (+1.13%)Earnings
- Q4 2023 Kura Oncology Inc Earnings Call TranscriptFeb 27, 2024€19 (+2.15%)Earnings
- Kura Oncology Inc To Discuss Preliminary Combo Data Call TranscriptJan 30, 2024
- Q3 2023 Kura Oncology Inc Earnings Call TranscriptNov 02, 2023€7.5 (-5.66%)Earnings
- Q2 2023 Kura Oncology Inc Earnings Call TranscriptAug 03, 2023€9.35 (+0.54%)Earnings
- Kura Oncology Inc Investor Day TranscriptJun 12, 2023
- Kura Oncology Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 Kura Oncology Inc Earnings Call TranscriptMay 10, 2023€10.4 (+2.97%)Earnings
- Kura Oncology Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 25, 2023
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Kura Oncology Inc Earnings Call TranscriptFeb 23, 2023€11.2 (+1.82%)Earnings
- Kura Oncology Inc ASH Investor Event Call TranscriptDec 10, 2022
- Kura Oncology Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kura Oncology Inc Earnings Call TranscriptNov 03, 2022€15.8 (-1.25%)Earnings
- Q2 2022 Kura Oncology Inc Earnings Call TranscriptAug 03, 2022€14.6 (+1.39%)Earnings
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Kura Oncology Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) TranscriptJun 02, 2022
- Q1 2022 Kura Oncology Inc Earnings Call TranscriptMay 04, 2022€14.1 (-0.70%)Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2022€12.2 (-3.17%)Earnings
- Kura Oncology Inc at Clinical Update Call TranscriptNov 24, 2021
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 Kura Oncology Inc Earnings Call TranscriptNov 04, 2021€15.7 (+6.80%)Earnings
- Kura Oncology Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Q2 2021 Kura Oncology Inc Earnings Call TranscriptAug 05, 2021€14.8 (-2.63%)Earnings
- Q1 2021 Kura Oncology Inc Earnings Call TranscriptMay 06, 2021€21.2Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Kura Oncology Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2021€27.2 (+0.74%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Kura Oncology Inc ASH Virtual Investor Event TranscriptDec 05, 2020
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 Kura Oncology Inc Earnings Call TranscriptNov 05, 2020€28.2 (-2.08%)Earnings
- Q2 2020 Kura Oncology Inc Earnings Call TranscriptAug 06, 2020€14.7 (+2.08%)Earnings
- Kura Oncology Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Kura Oncology Inc Earnings Call TranscriptMay 04, 2020€13.4 (-6.29%)Earnings
- Q4 2019 Kura Oncology Inc Earnings Call TranscriptFeb 25, 2020€11.5 (+1.77%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Kura Oncology Inc Earnings Call TranscriptNov 05, 2019€13.6 (+0.74%)Earnings
- Kura Oncology Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Kura Oncology Inc Earnings Call TranscriptAug 01, 2019€17.11 (+0.29%)Earnings
- Kura Oncology Inc EHA Data Review Conference Call TranscriptJun 14, 2019
- Kura Oncology Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kura Oncology Inc Earnings Call TranscriptMay 07, 2019€13.96 (+3.03%)Earnings
- Q4 2018 Kura Oncology Inc Earnings Call TranscriptMar 05, 2019€13.13 (-1.50%)Earnings
Kura Oncology Inc at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 06:25PM GMT
Release Date Price:
€13.1
(-2.96%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. Welcome, everyone, to the 31st Annual Healthcare Conference for Credit Suisse. We're joined today by Kura Oncology. We have Troy here, President and CEO of the company for a fireside chat. We're going to leave about 5 minutes towards the end of the presentation. If there are any questions from the audience. Otherwise, I just keep firing away until the time is up.
Questions & Answers
Tiago Felipe Fauth;dit Suisse AG;Troy Edward Wilson
CrÃ;Research Division - Research Analyst;Kura Oncology, Inc. - Chairman, CEO, President & Principal Financial Officer
© -
But I guess since you haven't had a public presence since the ASH abstracts were released, I know there was a lot of chat. So maybe too much focus on men in the near term, so we can probably start there. If you can just have your intro remarks, what are some of the key learnings from the abstract, and we'll take it from there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)